SE8301230L - Sett att framstella en amorf sterylglykosidmonopalmitatkomposition - Google Patents

Sett att framstella en amorf sterylglykosidmonopalmitatkomposition

Info

Publication number
SE8301230L
SE8301230L SE8301230A SE8301230A SE8301230L SE 8301230 L SE8301230 L SE 8301230L SE 8301230 A SE8301230 A SE 8301230A SE 8301230 A SE8301230 A SE 8301230A SE 8301230 L SE8301230 L SE 8301230L
Authority
SE
Sweden
Prior art keywords
compounds
composition
monopalmitates
fine particles
monopal
Prior art date
Application number
SE8301230A
Other languages
English (en)
Other versions
SE8301230D0 (sv
Inventor
S Inoue
M Kawamata
H Ushimaru
K Nakamichi
Y Takahashi
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13195074&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE8301230(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Publication of SE8301230L publication Critical patent/SE8301230L/sv
Publication of SE8301230D0 publication Critical patent/SE8301230D0/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J17/005—Glycosides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

Patentkrav 1. Sift aft framstalla en amorf sterylglukosidmonopalmitatkomoosition med fOrbattrad absorption i matsmaltnincsorganen kann.etecknatav att en forening vald fran dengrupp, scam utglires av beta-sitosteryl-glnkcsidmonopalmitat,stigmasteryl-glukosidmonopalmitat, kampesteryl-glukosidmonopalmitat och kolesteryl-glukosidmonopalmitat eller en blandning av vilken eller vilka mom heist darav loses i ett lagkokande ifs- ningsmedel, i vilket steryl-glukosidmonopalmitat Sr losligt, eller i en blandning av sadana lOsningsmedel, och lbsningsmedlet avdrives,varvid man eventuellt fOre upplOsningen till-salter en substans wad frau den grupp, sort utgbres my starkelse, cellulosa, laktos, polyvinylpyrolidcn, metylcellulosa, polyetylenglykol, gummi arabikum, magnesium-silikataluminat, kiselsyraanhydrid, syntetiskt aluminiumsilikat, magnesiumaluminiumhydroxid, aluminiumhydroxidael eller en blandninc av flagon eller nagra darav.

Claims (1)

Patentkrav
1. Sift aft framstalla en amorf sterylglukosidmonopalmitatkomoosition med fOrbattrad absorption i matsmaltnincsorganen kann.etecknatav att en forening vald fran dengrupp, scam utglires av beta-sitosteryl-glnkcsidmonopalmitat,stigmasteryl-glukosidmonopalmitat, kampesteryl-glukosidmonopalmitat och kolesteryl-glukosidmonopalmitat eller en blandning av vilken eller vilka mom heist darav loses i ett lagkokande ifs- ningsmedel, i vilket steryl-glukosidmonopalmitat Sr losligt, eller i en blandning av sadana lOsningsmedel, och lbsningsmedlet avdrives,varvid man eventuellt fOre upplOsningen till-salter en substans wad frau den grupp, sort utgbres my starkelse, cellulosa, laktos, polyvinylpyrolidcn, metylcellulosa, polyetylenglykol, gummi arabikum, magnesium-silikataluminat, kiselsyraanhydrid, syntetiskt aluminiumsilikat, magnesiumaluminiumhydroxid, aluminiumhydroxidael eller en blandninc av flagon eller nagra darav.
SE8301230A 1975-05-24 1983-03-07 Sett att framstella en amorf sterylglykosidmonopalmitatkomposition SE8301230D0 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP50062263A JPS51139613A (en) 1975-05-24 1975-05-24 An absorbable non-crystalline sterol glycoside monopalmitate ester and a method for preparing its pharmaceutical

Publications (2)

Publication Number Publication Date
SE8301230L true SE8301230L (sv) 1983-03-07
SE8301230D0 SE8301230D0 (sv) 1983-03-07

Family

ID=13195074

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7605686A SE431217B (sv) 1975-05-24 1976-05-19 Sett att framstella amorft sterylglukosidmonopalmitat
SE8301230A SE8301230D0 (sv) 1975-05-24 1983-03-07 Sett att framstella en amorf sterylglykosidmonopalmitatkomposition

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE7605686A SE431217B (sv) 1975-05-24 1976-05-19 Sett att framstella amorft sterylglukosidmonopalmitat

Country Status (10)

Country Link
US (1) US4129649A (sv)
JP (1) JPS51139613A (sv)
AT (1) AT352883B (sv)
BE (1) BE841949A (sv)
DE (1) DE2621222B2 (sv)
DK (1) DK226076A (sv)
FR (1) FR2312508A1 (sv)
GB (1) GB1489532A (sv)
NL (1) NL168522C (sv)
SE (2) SE431217B (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4260603A (en) * 1979-01-02 1981-04-07 Pegel Karl H Sterol glycoside with activity as prostaglandin synthetase inhibitor
JPS5874619A (ja) * 1981-10-29 1983-05-06 Nippon Shinyaku Co Ltd リポソ−ム及びその製法
US4614796A (en) * 1983-03-25 1986-09-30 Nippon Shinyaku Co., Ltd. Liposome and method of manufacture therefor
US5811547A (en) * 1992-10-14 1998-09-22 Nippon Shinyaju Co., Ltd. Method for inducing crystalline state transition in medicinal substance
AU5160793A (en) * 1992-10-14 1994-05-09 Nippon Shinyaku Co. Ltd. Crystalline condition dislocating method
ES2320998T3 (es) * 2003-04-02 2009-06-01 The Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services Compuestos que contienen colesterol y su uso como inmunogenos frente a borrelia burgdorferi.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2746957A (en) * 1952-09-23 1956-05-22 Benjamin Clayton Recovery of water soluble inositol compounds and sterol glycosides
US3036060A (en) * 1958-08-25 1962-05-22 Ciba Geigy Corp New organic compound
NL301747A (sv) * 1962-12-14
DE1962757C3 (de) * 1969-12-15 1979-11-15 Boehringer Mannheim Gmbh, 6800 Mannheim Evomonosid-Derivate, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittel
JPS5119719B2 (sv) * 1972-05-11 1976-06-19
JPS5637967B2 (sv) * 1973-05-17 1981-09-03
US3881005A (en) * 1973-08-13 1975-04-29 Lilly Co Eli Pharmaceutical dispersible powder of sitosterols and a method for the preparation thereof

Also Published As

Publication number Publication date
FR2312508B1 (sv) 1979-05-04
NL7605146A (nl) 1976-11-26
GB1489532A (en) 1977-10-19
JPS51139613A (en) 1976-12-02
SE7605686L (sv) 1976-11-25
DE2621222B2 (de) 1980-05-08
DE2621222A1 (de) 1976-12-02
DK226076A (da) 1976-11-25
BE841949A (fr) 1976-09-16
US4129649A (en) 1978-12-12
NL168522C (nl) 1983-09-16
FR2312508A1 (fr) 1976-12-24
SE8301230D0 (sv) 1983-03-07
JPS5523246B2 (sv) 1980-06-21
SE431217B (sv) 1984-01-23
AT352883B (de) 1979-10-10
NL168522B (nl) 1981-11-16

Similar Documents

Publication Publication Date Title
Huang et al. New taxanes from Taxus brevifolia, 2.
EP0360556B1 (en) New extracts of ginkgo biloba and their methods of preparation
SE8301230L (sv) Sett att framstella en amorf sterylglykosidmonopalmitatkomposition
Pereda-Miranda et al. Triterpenoids and flavonoids from Hyptis albida
EP1720884A1 (de) Pharmakologisch akzeptierbare salze von clopidogrel
Yoshimura et al. Constituents of seeds of Ailanthus altissima Swingle. Isolation and structures of shinjuglycosides A, B, C, and D.
JPH01153692A (ja) 高純度結晶ラクツロースの製造方法、及び得られる生成物
Quijano et al. The crystal structure of 6-epi-desacetyllaurenobiolide, a germacra-1 (10), 4-diene-12, 8α-olide from Montanoa grandiflora
Suksamrarn et al. Blechnosides A and B: ecdysteroid glycosides from Blechnum minus
US3166555A (en) Ammonium nitrate-hexamethylene-tetramine adduct
Hutchinson et al. The synthesis of esters of bilirubin
Buckley et al. Madagascarin, a new pigment from the leaves of Harungana madagascariensis
DE3461529D1 (en) Process for making spherical crystalline 5-hydroxytetracycline hydrochloride (oxytetracycline hydrochloride)
Sanz et al. New eudesmanolides related to torrentin from Artemisia herba-alba subsp. valentina
US2564609A (en) Process for preparing ryanodine
US3160640A (en) Method of extracting griseofulvin from mycelium and native solution
US6984725B2 (en) Method for the separation of triglycoalkaloids
Fonseca et al. Labriformin, a cardiac glucoside from Asclepias glaucescens
SU1162813A1 (ru) Способ получени (3,7-диметил-окта-2,6-диен-1,4-диол)-1-0- @ - @ -глюкопиранозида
SU555888A1 (ru) Способ получени полифенольных соединений,обладающих противовоспалительным действием
AU650572B2 (en) Crystalline etoposide 4'-phosphate diethanolate
DE936208C (de) Verfahren zur Herstellung von kristallisierten Glykosiden aus Folia Digitalis lanata
SU1162748A1 (ru) Способ получени активированного угл
DE4017766A1 (de) Neue saponine
AT248614B (de) Verfahren zur Herstellung von enterosolventen pharmazeutischen Präparaten

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8301230-2

Effective date: 19840929